Items Tagged ‘Samuel Di Piazza’

May 10, 2019

Mayo Clinic in the News Weekly Highlights for May 10, 2019

By Emily Blahnik eblahnik

New York Times, In This Doctor’s Office, a Physical Exam Like No Other by Carl Zimmer — To scientists like Michael Snyder, chair of the genetics department at Stanford University, the future of medicine is data — lots and lots of data. He and others predict that one day doctors won’t just take your blood […]

View full entry

Tags: active shooter training, alzheimer's disease, Biofourmis, CABANA, Cancer, cancer drugs, CBD oil, Christus St. Vincent Regional Medical Center, Chron's disease, Chronic Fatigue Syndrome, clinical trials, COPD


November 16, 2018

Mayo Clinic in the News Weekly Highlights for November 16, 2018

By Emily Blahnik eblahnik

Reuters, New drug options, risk factors added to U.S. heart guidelines by Deena Beasley — The new guidelines are fairly “conservative” in recommending that the newer drugs be used only after other options, said Dr. Francisco Lopez-Jimenez, a cardiologist at the Mayo Clinic in Rochester, Minnesota, adding “I think that was the right approach.” The […]

View full entry

Tags: ADHD, AI, alzheimer's disease, Anne Harguth, artificial Intelligence, carpal tunnel, Chateau Theater, childbirth, Colorectal Cancer, destination medical center, DMC, Dr. Amy Pollak


November 17, 2017

Mayo Trustee board re-elects chairman

By Karl W Oestreich KarlWOestreich

Post-Bulletin The Mayo Clinic Board of Trustees met Nov. 10 and re-elected its leadership. The 31-member board met in Minneapolis for a quarterly meeting and elected Samuel Di Piazza to continue in the role as chairman for another four years. Di Piazza is the retired CEO of PricewaterhouseCoopers. He joined the board in 2010 and […]

View full entry

Tags: Dr. John Noseworthy, Mayo Clinic Board of Trustees, Post Bulletin, Samuel Di Piazza


Contact Us · Privacy Policy